Obstructive Jaundice ICD-10-CM Codes | 2023

Which Obstructive Jaundice ICD codes are Billable: 

The billability of an ICD-10 code for obstructive jaundice depends on the patient's history, clinical context, provider's documentation, and payer's policies. Here are commonly used codes and their billability status.

• K83.0 - Obstruction of the bile duct: Yes. 
• K83.1 - Hydrops of the gallbladder: Yes. 
• K83.2 - Perforation of the bile duct: Yes. 
• K83.3 - Fistula of the bile duct: Yes. 
• K83.8 - Other specified diseases of the biliary tract: Yes. 
• K83.9 - Disease of the biliary tract, unspecified: Yes. 
• C22.0 - Liver cell carcinoma: Yes. 
• C24.0 - Malignant neoplasm of the extrahepatic bile duct: Yes. 
• C25.0 - Malignant neoplasm of the head of the pancreas: Yes. 
• K80.6 - Obstruction of the bile duct (other) without mention of calculus: Yes. 

ICD-10 codes may be billed differently based on various factors and payer requirements. Accurate clinical documentation is critical for billing and reimbursement. Healthcare providers, coders, and facilities must follow payer guidelines to determine code billability.

Clinical Information

• Patients with obstructive jaundice may present with yellowing of the skin and eyes (icterus), dark urine, pale stools, and generalized pruritus (itching). Other symptoms can include abdominal pain, nausea, and vomiting.
• Obstructive jaundice can result from various underlying causes, including gallstones, tumors (pancreatic, bile duct, or liver), strictures, cysts, or inflammation of the bile ducts.
• Healthcare providers may observe jaundice during the physical examination. Abdominal tenderness or palpable masses may be present, depending on the cause.
• Blood tests, such as elevated bilirubin levels, alkaline phosphatase, and transaminase, indicate obstructive jaundice. Liver function tests help assess liver damage.
• Imaging studies like ultrasound, CT scan, MRI, or endoscopic retrograde cholangiopancreatography (ERCP) can reveal the site and nature of the obstruction.
• ERCP and endoscopic ultrasound (EUS) can assist in diagnosing and treating bile duct obstructions by visualizing the biliary tree and performing interventions.
• In cases of suspected tumors or cancer, a biopsy may be necessary to determine the nature of the growth.
• Management depends on the cause. Surgical intervention may be required for tumor resection, and endoscopic procedures may be used to remove gallstones or place stents to relieve obstructions.
• Obstructive jaundice can lead to complications like cholangitis (infection of the bile duct), liver damage, and nutritional deficiencies due to impaired fat absorption.
• The prognosis varies based on the underlying cause and the timeliness of intervention. Early diagnosis and appropriate treatment are essential for a better outcome.
• Regular follow-up is necessary to monitor treatment progress, assess for recurrence, and manage any long-term consequences.
• A team of specialists, including gastroenterologists, hepatologists, surgeons, and oncologists, may care for patients with obstructive jaundice, ensuring a comprehensive approach to treatment and management.
• It is essential to educate patients about the underlying cause, treatment options, and the importance of adherence to medical recommendations to optimize their health and well-being.

Synonyms Include

• Cholestatic jaundice
• Biliary obstruction
• Cholestasis-induced jaundice
• Obstructive icterus
• Bile duct obstruction-associated jaundice